Cannabis clinic gets right against the National Board of Health and Welfare

0
106

Published 14 November 2022 at 10.42

Domestic. The National Board of Health and Welfare has torn up the Stockholm region's previous decision and allows the cannabis clinic Aureum Healthcare to continue prescribing cannabis-based medicines under the high-cost protection.

Like the article på Facebook

Aureum Healthcare is a medical practice in Stockholm that treats pain patients with medical cannabis.

Recently, the Stockholm region announced that they intended to suspend Aureum's ability to write prescriptions under the high-cost cover from October 10.

However, the National Board of Health and Welfare has decided to overturn the region's decision and allows the clinic to continue its operations as before.

– Above all, this is a victory for our patients. The region tried to use bureaucratic tricks to deny our patients the care they are entitled to by law. Now the National Board of Health and Welfare is listening to the region. says Christian Engström, press contact at Aureum Healthcare.

What Region Stockholm threatened with, technically, was to withdraw Aureum's “workplace code”. That code is needed for the doctors to be able to prescribe medicine that is covered by the high-cost protection. According to the Medicines Ordinance, “everyone who has a workplace and is authorized to prescribe medicines […] has the right to receive a workplace code”.

The region tried to withdraw the workplace code, and it is that decision that the National Board of Health and Welfare is now revoking.< /p>

– I am happy for the reception's patients. There has been an enormous fear among them when they realized that due to the Region's decision to remove the drug subsidy for these preparations, they might have to return to pain relief with opiate-based and highly addictive drugs, such drugs as they have today received help from the clinic to be phased out.

The region has appealed the decision.

“In the review of Aureum's workplace code, we assess that, based on the data, it is not possible to determine whether the drug prescription is patient safe,” the region writes in a statement according to Mitti.